Market Closed -
Bombay S.E.
06:01:04 2024-06-05 am EDT
|
5-day change
|
1st Jan Change
|
40.73
INR
|
+3.35%
|
|
-2.82%
|
-26.05%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
592.7
|
191.3
|
87.12
|
371.8
|
801.3
|
1,239
|
Enterprise Value (EV)
1 |
945.3
|
514
|
404
|
640.9
|
1,088
|
1,502
|
P/E ratio
|
91.8
x
|
-4.05
x
|
-10.9
x
|
7.43
x
|
9.73
x
|
10.9
x
|
Yield
|
-
|
-
|
-
|
2.02%
|
1.92%
|
0.83%
|
Capitalization / Revenue
|
0.73
x
|
0.23
x
|
0.11
x
|
0.39
x
|
0.59
x
|
0.97
x
|
EV / Revenue
|
1.16
x
|
0.61
x
|
0.53
x
|
0.68
x
|
0.8
x
|
1.18
x
|
EV / EBITDA
|
14.9
x
|
-119
x
|
10.7
x
|
5.96
x
|
6.61
x
|
7.93
x
|
EV / FCF
|
-5.17
x
|
16.8
x
|
-18
x
|
31.5
x
|
-18
x
|
-138
x
|
FCF Yield
|
-19.4%
|
5.96%
|
-5.57%
|
3.17%
|
-5.56%
|
-0.72%
|
Price to Book
|
1.5
x
|
0.55
x
|
0.26
x
|
0.92
x
|
1.54
x
|
2.01
x
|
Nbr of stocks (in thousands)
|
15,063
|
15,063
|
15,021
|
15,021
|
20,521
|
20,521
|
Reference price
2 |
39.35
|
12.70
|
5.800
|
24.75
|
39.05
|
60.39
|
Announcement Date
|
9/4/18
|
9/4/19
|
9/7/20
|
8/23/21
|
8/13/22
|
8/10/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
815.4
|
846.7
|
766.9
|
945.1
|
1,367
|
1,278
|
EBITDA
1 |
63.48
|
-4.303
|
37.61
|
107.6
|
164.6
|
189.4
|
EBIT
1 |
37.6
|
-31.91
|
8.305
|
76.48
|
124.4
|
146.7
|
Operating Margin
|
4.61%
|
-3.77%
|
1.08%
|
8.09%
|
9.1%
|
11.48%
|
Earnings before Tax (EBT)
1 |
3.857
|
-62.56
|
-7.912
|
46.84
|
114.3
|
153.6
|
Net income
1 |
5.168
|
-47.16
|
-8.011
|
50.06
|
82.32
|
113.5
|
Net margin
|
0.63%
|
-5.57%
|
-1.04%
|
5.3%
|
6.02%
|
8.88%
|
EPS
2 |
0.4288
|
-3.140
|
-0.5333
|
3.333
|
4.011
|
5.530
|
Free Cash Flow
1 |
-182.9
|
30.65
|
-22.51
|
20.34
|
-60.44
|
-10.86
|
FCF margin
|
-22.44%
|
3.62%
|
-2.93%
|
2.15%
|
-4.42%
|
-0.85%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
18.91%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
40.63%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
0.5000
|
0.7500
|
0.5000
|
Announcement Date
|
9/4/18
|
9/4/19
|
9/7/20
|
8/23/21
|
8/13/22
|
8/10/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
353
|
323
|
317
|
269
|
286
|
263
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.553
x
|
-75
x
|
8.427
x
|
2.501
x
|
1.739
x
|
1.387
x
|
Free Cash Flow
1 |
-183
|
30.7
|
-22.5
|
20.3
|
-60.4
|
-10.9
|
ROE (net income / shareholders' equity)
|
1.56%
|
-12.7%
|
-2.32%
|
13.4%
|
17.8%
|
20%
|
ROA (Net income/ Total Assets)
|
2.76%
|
-2.15%
|
0.62%
|
5.6%
|
8.14%
|
8.12%
|
Assets
1 |
187.4
|
2,192
|
-1,291
|
893.7
|
1,012
|
1,398
|
Book Value Per Share
2 |
26.30
|
23.20
|
22.60
|
27.00
|
25.30
|
30.10
|
Cash Flow per Share
2 |
0.4900
|
3.260
|
1.960
|
2.540
|
2.610
|
2.500
|
Capex
1 |
101
|
10.7
|
52.6
|
31.6
|
108
|
165
|
Capex / Sales
|
12.33%
|
1.26%
|
6.86%
|
3.34%
|
7.93%
|
12.95%
|
Announcement Date
|
9/4/18
|
9/4/19
|
9/7/20
|
8/23/21
|
8/13/22
|
8/10/23
|
|
1st Jan change
|
Capi.
|
---|
| -26.05% | 9.68M | | +4.86% | 104B | | -10.06% | 60.79B | | +82.86% | 51.13B | | +14.74% | 38.21B | | -0.52% | 30.75B | | +10.55% | 19.83B | | +10.49% | 16.5B | | +7.90% | 13.82B | | -2.61% | 13.33B |
Other Commodity Chemicals
|